tiprankstipranks
Trending News
More News >
Concord Healthcare Group Co., Ltd. Class H (HK:2453)
:2453
Hong Kong Market
Advertisement

Concord Healthcare Group Co., Ltd. Class H (2453) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Concord Healthcare Group Co., Ltd. Class H has a market cap or net worth of ―. The enterprise value is HK$7.57B.
Market Cap
Enterprise ValueHK$7.57B

Share Statistics

Concord Healthcare Group Co., Ltd. Class H has 265,151,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding265,151,030
Owned by Insiders
Owned by Institutions

Financial Efficiency

Concord Healthcare Group Co., Ltd. Class H’s return on equity (ROE) is -0.27 and return on invested capital (ROIC) is -7.16%.
Return on Equity (ROE)-0.27
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-7.16%
Return on Capital Employed (ROCE)-0.08
Revenue Per Employee684.84K
Profits Per Employee-781.70K
Employee Count567
Asset Turnover0.07
Inventory Turnover13.62

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio
PS Ratio0.00
PB Ratio2.72
Price to Fair Value4.49
Price to FCF-24.55
Price to Operating Cash Flow-24.05
PEG Ratio-1.16

Income Statement

In the last 12 months, Concord Healthcare Group Co., Ltd. Class H had revenue of 388.31M and earned -443.22M in profits. Earnings per share was -0.62.
Revenue388.31M
Gross Profit-67.25M
Operating Income-371.21M
Pretax Income-485.85M
Net Income-443.22M
EBITDA-194.46M
Earnings Per Share (EPS)-0.62

Cash Flow

In the last 12 months, operating cash flow was -186.01M and capital expenditures -42.89K, giving a free cash flow of -186.05M billion.
Operating Cash Flow-186.01M
Free Cash Flow-186.05M
Free Cash Flow per Share-0.70

Dividends & Yields

Concord Healthcare Group Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.54
52-Week Price Change-83.99%
50-Day Moving Average6.35
200-Day Moving Average9.88
Relative Strength Index (RSI)62.99
Average Volume (3m)21.32M

Important Dates

Concord Healthcare Group Co., Ltd. Class H upcoming earnings date is ―, ―.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

Concord Healthcare Group Co., Ltd. Class H as a current ratio of 0.63, with Debt / Equity ratio of 194.79%
Current Ratio0.63
Quick Ratio0.60
Debt to Market Cap0.42
Net Debt to EBITDA-15.45
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Concord Healthcare Group Co., Ltd. Class H has paid -1.03M in taxes.
Income Tax-1.03M
Effective Tax Rate<0.01

Enterprise Valuation

Concord Healthcare Group Co., Ltd. Class H EV to EBITDA ratio is -53.47, with an EV/FCF ratio of -20.33.
EV to Sales26.78
EV to EBITDA-53.47
EV to Free Cash Flow-20.33
EV to Operating Cash Flow-55.91

Balance Sheet

Concord Healthcare Group Co., Ltd. Class H has HK$337.12M in cash and marketable securities with ¥3.21B in debt, giving a net cash position of HK$2.87B billion.
Cash & Marketable SecuritiesHK$337.12M
Total Debt¥3.21B
Net CashHK$2.87B
Net Cash Per ShareHK$10.83
Tangible Book Value Per ShareHK$1.50

Margins

Gross margin is -17.32%, with operating margin of -95.60%, and net profit margin of -114.14%.
Gross Margin-17.32%
Operating Margin-95.60%
Pretax Margin-125.12%
Net Profit Margin-114.14%
EBITDA Margin-50.08%
EBIT Margin-79.45%

Analyst Forecast

The average price target for Concord Healthcare Group Co., Ltd. Class H is HK$6.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$6.00
Price Target Upside-14.41% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-29.41%
EPS Growth Forecast-16.52%

Scores

Smart ScoreN/A
AI Score44.6
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis